Signaling Diversity Among Gqa Family Members

体现 Gqa 家族成员的多样性

基本信息

  • 批准号:
    6769560
  • 负责人:
  • 金额:
    $ 26.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-02 至 2006-06-30
  • 项目状态:
    已结题

项目摘要

Many hormones and neurotransmitters rely on the Gq class of heterotrimeric G proteins (Gq/11alpha, G14alpha, and G15/16alpha) to exert their actions at target issues. Gqalpha family members activate PLCbeta and inositol lipid signaling, and established models suggest that the cellular actions of these Galpha are identical and result from activation of Ca PKC pathways. However compelling evidence now indicated that Gq/11alpha, G14alpha, and G15/16alpha differ markedly in their overall cellular responses, their interactions with certain protein binding partners, and their cellular and biochemical properties. Contrary to established models, my working hypothesis is that Gq/11alpha, G14alpha and G15/16alpha regulate multiple overlapping and distinct signaling cascades, and are regulated differently by host cells to elicit a distinct profile of cellular responses. Consistent with this idea, Gqalph family members are expressed in different cells, and Gqalpha interacts with multiple signaling proteins besides PLCbeta, though the relative contribution of each binding partner to Gqalpha signaling is unknown. Furthermore, Gq/11alpha, G14alpha and G15/16alpha share only 57 percent overall amino acid identity, and just 12 percent identity within their first 35 residues (N- terminus) which contains fatty acids that are essential for regulating Galpha signaling capacity. Although the acylation state of G14alpha and G15/16alpha is unknown, sequence alignments predict that Gqalpha family members are modified differently. Using modem molecular, cellular, and biochemical approaches study G protein functions, the specific aims will be to: 1. Define biochemical modifications present on Gq/11alpha, G14alpha, and G15/16alpha important for regulating signaling functions. 2. Define factors that regulate Gq/11alpha, G14alpha and G15/16alpha signaling capacity including target subcelluar localization and interactions with protein binding partners. 3. Determine the diversity of cell signaling responses elicited by Gqalpha, G14alpha and G15/16alpha in selected cells, and the relative contribution of Galpha binding partners to those responses. Heterotrimeric G proteins serve essential roles in cell physiology by inking cell surface receptors to intracellular responses. G protein dysfunction is the direct cause of a growing list of human diseases, and the majority of currently available drugs exert their actions on G protein signaling pathways. These experiments will determine functional correlates for the biochemical differences observed among the Gqalpha family of G proteins, and offer new insights into the diversity and regulation of signaling responses elicited by these important G proteins. Information gained from these studies will help us to better understand G proteins as therapeutic targets.
许多激素和神经递质依赖于Gq类异源三聚体G蛋白(Gq/11 α,G14 α和G15/16 α)在靶点发挥作用。 Gq α家族成员激活PLC β和肌醇脂质信号传导,并且建立的模型表明这些G α的细胞作用是相同的,并且是由Ca PKC途径激活引起的。 然而,现在令人信服的证据表明,Gq/11 α,G14 α和G15/16 α在它们的整体细胞反应,它们与某些蛋白质结合伴侣的相互作用以及它们的细胞和生化特性方面显着不同。 与已建立的模型相反,我的工作假设是Gq/11 α,G14 α和G15/16 α调节多个重叠和不同的信号级联,并由宿主细胞不同地调节,以引起不同的细胞反应谱。 与这一想法一致,Gqalph家族成员在不同的细胞中表达,并且Gqalpha与除了PLC β之外的多种信号传导蛋白相互作用,尽管每个结合伴侣对Gqalpha信号传导的相对贡献是未知的。 此外,Gq/11 α、G14 α和G15/16 α仅共享57%的总体氨基酸同一性,并且在它们的前35个残基(N-末端)内仅共享12%的同一性,所述前35个残基含有对于调节G α信号传导能力至关重要的脂肪酸。 虽然G14 α和G15/16 α的酰化状态是未知的,但序列比对预测Gq α家族成员的修饰不同。本论文运用现代分子、细胞和生物化学方法研究G蛋白的功能,具体目的是:1。定义存在于Gq/11 α,G14 α和G15/16 α上的对调节信号功能重要的生化修饰。2.定义调节Gq/11 α、G14 α和G15/16 α信号传导能力的因素,包括靶向亚细胞定位和与蛋白质结合伴侣的相互作用。3.确定Gq α、G14 α和G15/16 α在选定细胞中引发的细胞信号传导反应的多样性,以及Gq α结合配偶体对这些反应的相对贡献。异源三聚体G蛋白通过将细胞表面受体与细胞内反应联系起来在细胞生理学中起重要作用。 G蛋白功能障碍是越来越多的人类疾病的直接原因,目前大多数可用的药物都对G蛋白信号通路发挥作用。 这些实验将确定G蛋白的Gqalpha家族之间观察到的生化差异的功能相关性,并提供新的见解的多样性和调节这些重要的G蛋白引起的信号反应。 从这些研究中获得的信息将有助于我们更好地了解G蛋白作为治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN R HEPLER其他文献

JOHN R HEPLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN R HEPLER', 18)}}的其他基金

Decoding the RGS14 Interactome/Signalosome in CA2 hippocampal neurons
解码 CA2 海马神经元中的 RGS14 Interactome/Signalosome
  • 批准号:
    9021004
  • 财政年份:
    2015
  • 资助金额:
    $ 26.6万
  • 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
  • 批准号:
    8250157
  • 财政年份:
    2011
  • 资助金额:
    $ 26.6万
  • 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
  • 批准号:
    8322591
  • 财政年份:
    2011
  • 资助金额:
    $ 26.6万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7460544
  • 财政年份:
    2006
  • 资助金额:
    $ 26.6万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7860719
  • 财政年份:
    2006
  • 资助金额:
    $ 26.6万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7261259
  • 财政年份:
    2006
  • 资助金额:
    $ 26.6万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7142629
  • 财政年份:
    2006
  • 资助金额:
    $ 26.6万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7635827
  • 财政年份:
    2006
  • 资助金额:
    $ 26.6万
  • 项目类别:
Signaling Diversity Among Gqa Family Members
体现 Gqa 家族成员的多样性
  • 批准号:
    6520320
  • 财政年份:
    2001
  • 资助金额:
    $ 26.6万
  • 项目类别:
Signaling Diversity Among Gqa Family Members
体现 Gqa 家族成员的多样性
  • 批准号:
    6370836
  • 财政年份:
    2001
  • 资助金额:
    $ 26.6万
  • 项目类别:

相似国自然基金

TLS聚合酶Polη乙酰化修饰的动态调控和功能研究
  • 批准号:
    31970740
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.6万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.6万
  • 项目类别:
    Research Grant
Discovery of phosgene and chlorine gas modes of action and therapeutic targets using chemoproteomic profiling strategies
使用化学蛋白质组学分析策略发现光气和氯气的作用模式和治疗靶点
  • 批准号:
    10883970
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Time-restricted eating: Is it an efficacious tool for weight loss maintenance
限时饮食:是减肥维持的有效工具吗
  • 批准号:
    10591316
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Project 1
项目1
  • 批准号:
    10762160
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function from Various Organisms for the Development of Antibiological Agents
检查不同生物体的鸟氨酸脱羧酶抗酶 RNA 结构和功能,用于开发抗生素
  • 批准号:
    10730595
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
MICT1 function in thermogenesis
MICT1 在生热作用中的功能
  • 批准号:
    10570388
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease
多组学数据整合方法发现阿尔茨海默病的假定因果变异、基因和患者异质性
  • 批准号:
    10587524
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
碳水化合物和糖复合物的化学合成和生物应用
  • 批准号:
    10552167
  • 财政年份:
    2023
  • 资助金额:
    $ 26.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了